Opportunity Overview
Recently, the Ciccarelli lab performed a multi-omic profile of immunotherapy-treated colorectal cancers showing that responsive tumours are characterised by deregulation of interferon-g pathways and rich infiltration of T cells and antigen-presenting tumour associated macrophages (TAMs), which engage in PD1/PDL1-mediated interactions1. The role of TAMs in the TME is unknown but they are likely to modulate anti-tumour immunity. Using spontaneous murine cancer models, the Arnold lab have identified interferon-regulated TAMs, which may be analogous to those in human cancer.
This translational and inter-disciplinary project will further characterise the role of this interferon regulated/CD74+ TAM subset(s) in the tumour microenvironment of murine and human tumours and their role in the response to immunotherapy.
This project will dissect the role of CD74+ TAMs and their role in the anti-tumour immune response through the following overarching project aims:
1) Employ spatial transcriptomics and imaging mass cytometry of immunotherapy-treated human gastrointestinal cancers and murine tumours to deeply phenotype (CD74+ /interferon-regulated TAMs and characterise their interactions with T cells in tissues sections.
2) Analyse transcriptomic datasets and employ computational approaches alongside in vivo models and in vitro culture techniques to identify candidate mediators of CD74+ TAM polarisation and recruitment at the tumour site, with a primary focus on studying the role of IFN-gamma as a key candidate polarisation molecule.
3) Mechanistically resolve the relationship between TAMs and their modulation of T cell responses via gene knockout and therapeutic intervention in murine models of...
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | MRC |
|---|---|
| Country | United Kingdom |
| Category | Research Development |
| Published | September 30, 2022 |
| Procurement stage | Active solicitation |
| Closed | September 29, 2026 |
| Status | Closed — no longer accepting responses |
| Official source | View original notice |
| Last verified | August 10, 2026 |
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
Browse Similar Open Opportunities in United Kingdom
See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United Kingdom Research Development intelligence report in your inbox
A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.